Relevant bibliographies by topics / Poliomyelitis – Vaccination

Academic literature on the topic 'Poliomyelitis – Vaccination'

Author: Grafiati
Published: 10 December 2022
Last updated: 28 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Poliomyelitis – Vaccination.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Poliomyelitis – Vaccination"

1

Chamberlain, R. "Poliomyelitis vaccination." BMJ 295, no. 6591 (July 18, 1987): 158–59. http://dx.doi.org/10.1136/bmj.295.6591.158.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Melnick, Joseph L. "Poliomyelitis Vaccination." Clinical Immunotherapeutics 6, no. 1 (July 1996): 1–6. http://dx.doi.org/10.1007/bf03259348.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Langhorst, Silvan Elias, Niklas Frahm, Michael Hecker, Pegah Mashhadiakbar, Barbara Streckenbach, Julia Baldt, Felicita Heidler, and Uwe Klaus Zettl. "Vaccination Coverage against Tetanus, Diphtheria, Pertussis and Poliomyelitis and Validity of Self-Reported Vaccination Status in Patients with Multiple Sclerosis." Journal of Personalized Medicine 12, no. 5 (April 23, 2022): 677. http://dx.doi.org/10.3390/jpm12050677.

Full text
Abstract:
Multiple sclerosis (MS) is a chronic immune-mediated disease with a neurodegenerative component of the central nervous system. Immunomodulatory therapy can increase the risk of infection, which is a particular risk for MS patients. Therefore, a complete vaccination status is of utmost importance as protection against vaccine-preventable infectious diseases. Our aim was to investigate the vaccination status, vaccination card knowledge and the vaccination behavior of MS patients with regard to vaccinations against tetanus, diphtheria, pertussis and poliomyelitis. Three hundred twenty-seven patients with MS were evaluated by anamnesis, clinical examination, structured interview and vaccination card control in this two-center study. Based on the recommendations of the Robert Koch Institute, we assessed the completeness of the vaccination status of the examined vaccinations. Furthermore, a comparative analysis of patients with complete/incomplete or correctly/wrongly self-reported vaccination status was performed. In the cohort analyzed, the vaccination coverage was 79.5% for tetanus, 79.2% for diphtheria, 74.8% for pertussis and 84.8% for poliomyelitis. The assumed vaccination status was higher for tetanus (86.5%) and lower for diphtheria (69.4%), pertussis (61.2%) and poliomyelitis (75.9%). Patients who were unvaccinated or only partially vaccinated against tetanus had received vaccination advice from a physician less often in the past year (13.4 vs. 36.9%, p < 0.001) and had no one to check the vaccination card more often (35.8 vs. 12.3%, p < 0.001). High sensitivity (93.7%) and low specificity (30.3%) were determined regarding the validity of self-reported tetanus vaccination status. Patients with a correctly reported tetanus vaccination status were more likely to have their vaccination card checked by a physician than those who overestimated or underestimated their vaccination status (76.7 vs. 63.0/43.8%, p = 0.002). Similar findings were seen with regard to diphtheria, pertussis and poliomyelitis vaccination. Patients without a regular vaccination card control (17.1%) were more likely to be male (44.6 vs. 29.4%, p = 0.037), had fewer siblings on average (1.1 vs. 1.6, p = 0.016), dealt less frequently with the issue of vaccination in the past year (32.1 vs. 69.3%, p < 0.001) and more frequently had the wish to receive vaccination advice (48.2 vs. 34.4%, p = 0.030) than patients in whom the vaccination card was checked regularly by a physician. To minimize the risk of infection in MS patients, treating physicians should provide regular vaccination counseling and perform vaccination card controls, as these factors are associated with a higher vaccination coverage and a higher validity of self-reported vaccination statuses.
APA, Harvard, Vancouver, ISO, and other styles
4

Tian, Maoqiang, Jing Yang, Lei Li, Juan Li, Wenting Lei, and Xiaomei Shu. "Vaccine-Associated Neurological Adverse Events: A Case Report and Literature Review." Current Pharmaceutical Design 25, no. 43 (January 9, 2020): 4570–78. http://dx.doi.org/10.2174/1381612825666191119095132.

Full text
Abstract:
Vaccination is an effective strategy to reduce the burden of preventable illness. However, many clinical reports revealed that various vaccinations may associate with neurological disorders, mainly including autoimmune disease, febrile seizure, and vaccine-associated paralytic poliomyelitis (VAPP). Although more and more reports revealed that part of the above post-vaccine neurological disorders is not directly related to vaccination, it may be merely a coincidence. However, these reports may increase the hesitancy on vaccination for the public population and influence the coverage of vaccination. In this report, we described a child with acute flaccid paralysis possibly caused by a poliovirus vaccine. To provide feasible ways to realize or reduce the risk of neurological adverse events caused by vaccines, we further provide a mini-review of the literature of vaccination associated with neurological adverse events. This revealed that oral poliomyelitis vaccine use exclusively and type 2 serotype poliomyelitis vaccine virus were the risk factors for VAPP. The combination vaccine was associated with an increased risk of ADEM and FS following immunization when compared with the administration of vaccines separately. Even though cases have been reported that vaccination may be a trigger of anti-NMDARe and GBS, there is no direct evidence to prove that vaccination increased the risk of GBS and anti-NMDARe.
APA, Harvard, Vancouver, ISO, and other styles
5

Maltezou, Helena C., Christos Rahiotis, Maria Tseroni, Phoebus Madianos, and Ioannis Tzoutzas. "Attitudes toward Vaccinations and Vaccination Coverage Rates among Dental Students in Greece." International Journal of Environmental Research and Public Health 19, no. 5 (March 1, 2022): 2879. http://dx.doi.org/10.3390/ijerph19052879.

Full text
Abstract:
Our aim was to study attitudes toward vaccinations, full vaccination rates and susceptibility rates against vaccine-preventable diseases among students attending a University Dental School. A total of 134 students were studied. Full vaccination rates were as follows: 56.5% against measles and mumps, 70.6% against rubella, 32.3% against varicella, 44.1% against hepatitis A, 45.9% against hepatitis B, and 87.7% against COVID-19. In the past decade, 63.2% of students had received a booster shot against tetanus–diphtheria, 47.8% against pertussis, and 28.1% against poliomyelitis, while 29.4% of students had been vaccinated against influenza in the past year. Susceptibility rates were 40.4% for measles, 42.4% for mumps, 28.3% for rubella, 32.3% for varicella, 55.3% for hepatitis A, 54.1% for hepatitis B, 36.8% for tetanus–diphtheria, 52.2% for pertussis, and 71.9% for poliomyelitis. Overall, 123 (91.8%) students favored mandatory vaccinations, mainly for all dentists (88.4%), while 11.6% of students favored them only for dentists who provide care to high-risk patients. In conclusion, most dental students favored mandatory vaccinations, yet we found significant vaccination gaps and susceptibility rates against vaccine-preventable diseases. Vaccinations for dental students should be intensified. A national vaccination registry for healthcare personnel including dental students is urgently needed.
APA, Harvard, Vancouver, ISO, and other styles
6

Arnold, Jana Nele, Nils Gundlach, Irina Böckelmann, and Stefan Sammito. "Impfstatus von jungen Arbeitnehmern – Eine Erhebung bei Berufsanfängern der Bundeswehr." ASU Arbeitsmedizin Sozialmedizin Umweltmedizin 2020, no. 12 (November 27, 2020): 770–75. http://dx.doi.org/10.17147/asu-2012-8715.

Full text
Abstract:
Vaccination status of young employees: A survey of entrants in the Bundeswehr (German Federal Armed Forces) Objectives: In addition to the recommendations of the Standing Committee on Vaccination (STIKO) at the Robert-Koch-Institut, there are also jobrelated vaccination recommendations for special occupational groups. This applies equally to soldiers, but there is insufficient scientific data on vaccination rates. For this reason, the following study examined the extent of the vaccination gaps among young people entering the armed forces. Methods: As part of a cross-sectional study at Rotenburg (Wümme), Lower Saxony, the existing vaccination rates among soldiers in relation to tetanus, diphtheria, poliomyelitis, pertussis, measles, mumps, rubella, hepatitis A, hepatitis B and tick-borne encephalitis (TBE) were recorded and compared statistically between the three recruitment quarters (II/ to IV/2016). Results: The vaccination booklets of 247 recruits (age: 20.5 ± 2.7 years) from three quarters were recorded. The rate of unavailable vaccination booklets was 23.1 %. The vaccination rates were between 2 % for TBE and 75 % for measles. Whilst low vaccination protection rates were identified for TBE and hepatitis A/B in particular, the rates were also found to be as low as 44–60 % for the „typical“ tetanus, poliomyelitis and diphtheria vaccinations. There were high numbers of „expired“ full protection: these ranged from 19 % (diphtheria) to 50 % (hepatitis B). Conclusions: The results of the study indicate a clear lack of vaccination protection in a random sample of German citizens with an average age of 20 who started their service in the Bundeswehr as young professionals. Although, as expected, this was very low for vaccinations that are not standard STIKO vaccinations (hepatitis A, TBE), there were also significant vaccine deficiencies in the vaccinations recommended by STIKO in the young adults examined here. Keywords: military – vaccination – prevention – infection disease
APA, Harvard, Vancouver, ISO, and other styles
7

Greco, Donato, Lucia Fiore, Alexander Sallabanda, and Heleni Diamanti. "Poliomyelitis vaccination strategies for Europe." Lancet 349, no. 9049 (February 1997): 437. http://dx.doi.org/10.1016/s0140-6736(97)80066-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wassilak, Steven GF, George P. Oblapenko, Sieghart Dittmann, R. Bruce Aylward, and Harry F. Hull. "Poliomyelitis vaccination strategies for Europe." Lancet 349, no. 9049 (February 1997): 437. http://dx.doi.org/10.1016/s0140-6736(05)65063-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Slater, Paul E. "Poliomyelitis vaccination: the essential booster." Vaccine 9, no. 7 (July 1991): 527. http://dx.doi.org/10.1016/0264-410x(91)90049-c.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

van Wijhe, M., A. D. Tulen, H. Korthals Altes, S. A. McDonald, H. E. de Melker, M. J. Postma, and J. Wallinga. "Quantifying the impact of mass vaccination programmes on notified cases in the Netherlands." Epidemiology and Infection 146, no. 6 (March 14, 2018): 716–22. http://dx.doi.org/10.1017/s0950268818000481.

Full text
Abstract:
AbstractVaccination programmes are considered a main contributor to the decline of infectious diseases over the 20th century. In recent years, the national vaccination coverage in the Netherlands has been declining, highlighting the need for continuous monitoring and evaluation of vaccination programmes. Our aim was to quantify the impact of long-standing vaccination programmes on notified cases in the Netherlands. We collected and digitised previously unavailable monthly case notifications of diphtheria, poliomyelitis, mumps and rubella in the Netherlands over the period 1919–2015. Poisson regression models accounting for seasonality, multi-year cycles, secular trends and auto-correlation were fit to pre-vaccination periods. Cases averted were calculated as the difference between observed and expected cases based on model projections. In the first 13 years of mass vaccinations, case notifications declined rapidly with 82.4% (95% credible interval (CI): 74.9–87.6) of notified cases of diphtheria averted, 92.9% (95% CI 85.0–97.2) cases of poliomyelitis, and 79.1% (95% CI 67.1–87.4) cases of mumps. Vaccination of 11-year-old girls against rubella averted 49.9% (95% CI 9.3–73.5) of cases, while universal vaccination averted 68.1% (95% CI 19.4–87.3) of cases. These findings show that vaccination programmes have contributed substantially to the reduction of infectious diseases in the Netherlands.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Poliomyelitis – Vaccination"

1

Трунова, Інна Олександрівна, Инна Александровна Трунова, Inna Oleksandrivna Trunova, and Б. В. Липівець. "Проблема вакцинації в Україні." Thesis, Сумський державний університет, 2016. http://essuir.sumdu.edu.ua/handle/123456789/45395.

Full text
Abstract:
19-го жовтня в Україні стартував перший раунд додаткової імунізації проти поліомієліту. Цьому передував довгий період пошуку вакцини проти вірусу й дискусії щодо її безпечності. Всесвітня організація охорони здоров’я підтвердила два випадки захворювання на поліомієліт. Вірус виявили у чотирирічної та 11-ти місячної дитини. Ці випадки стали першими в Україні після 2006-го року.
APA, Harvard, Vancouver, ISO, and other styles
2

Голяр, О. І., and А. В. Панчошак. "Проблема імунопрофілактики поліомієліту в Україні." Thesis, Сумський державний університет, 2016. http://essuir.sumdu.edu.ua/handle/123456789/45385.

Full text
Abstract:
Дo тoго часy поки в свiтi залишається хоча б одна iнфiкована дитина, ризикy заражeння полiомiєлiтом пiддаються дiти всiх країн. Берyчи до yваги серйознi наслiдки захворювання, а також вiдсyтнiсть етiотропного лiкyвання, доцiльнiсть проведення вакцинацiї не залишає сумнiвiв. Вакцинацiя – це єдиний ефективний метод боротьби з полiомiєлiтом.
APA, Harvard, Vancouver, ISO, and other styles
3

Oliveira, Thairiane Guimarães. "Completude e atraso da vacinação contra poliomielite antes e após a substituição da vacina oral pela injetável." Universidade Federal de Goiás, 2018. http://repositorio.bc.ufg.br/tede/handle/tede/8703.

Full text
Abstract:
Submitted by Liliane Ferreira (ljuvencia30@gmail.com) on 2018-07-17T13:12:41Z No. of bitstreams: 2 Dissertação - Thairiane Guimarães Oliveira - 2018.pdf: 3935527 bytes, checksum: b2d64a8b08632bbd37415a47356f6a37 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)
Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2018-07-17T13:45:37Z (GMT) No. of bitstreams: 2 Dissertação - Thairiane Guimarães Oliveira - 2018.pdf: 3935527 bytes, checksum: b2d64a8b08632bbd37415a47356f6a37 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)
Made available in DSpace on 2018-07-17T13:45:37Z (GMT). No. of bitstreams: 2 Dissertação - Thairiane Guimarães Oliveira - 2018.pdf: 3935527 bytes, checksum: b2d64a8b08632bbd37415a47356f6a37 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Previous issue date: 2018-05-23
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES
INTRODUCTION: The oral polio vaccine (OPV) can cause a vaccine-derived poliovirus, which is a deterrent to the complete eradication of the disease. Globally, there is a gradual replacement of OPV by the poliomyelitis vaccine (VIP). Brazil has adopted an IPV-OPV mixed schedule since 2012, but no study was conducted to evaluate and compare the completeness and delay of vaccinations before and after the replacement of the oral vaccination with the inactivated poliovirus vaccination. OBJECTIVES: To compare the completion and delay of vaccination of children under 12 months of age before and after the introduction of the VIP vaccine in routine vaccination. METHODOLOGY: Before-and-after study with two live birth cohorts in the city of Goiânia, Goiás. A cohort of live births in 2010 received the vaccine regimen exclusively with OPV, and another cohort of live births in 2014 received the mixed vaccine regimen IPV-OPV. Two sources of nominal secondary data were used: the Ambulatory Care Control System, which contains data on vaccines and the Live Birth Information System, which contains data on the child and the mother. Completeness of vaccination schedule was defined as the receipt of three valid doses from the primary series up to 12 months of age. Vaccination delay was defined as the dose of vaccine given >28 days after the recommended age. The SICAA and SINASC databases were linked by deterministic linkage to identify the records of the same child. The follow-up time for each child was 12 months. RESULTS: A total of 23,335 children were included, 9,563 of the cohort born in 2010 and 13,772 of the cohort born in 2014. The proportion of children who received the IPV-OPV mixed regimen presented 78.0% of vaccine completeness, while the proportion of children who received only OPV schedule presented 72.4% of vaccine completeness (p=0.000). A higher proportion of vaccine delay of the 1st dose was observed: 6.9% and 5.8%, the second dose was 25.4% and 18.2%, and the third dose was 31.1% and 19.3% for the IPV-OPV and exclusively VOP vaccination schemes, respectively. Children who received the IPV-OPV mixed schedule had a highest median age at all doses, more days of delay and longer intervals between doses, when compared to children who received the OPV schedule. CONCLUSION: Children who received the VIP-VOP mixed schedule presented higher vaccine delay, but a greater proportion of vaccine completeness when compared to the children who received only OPV schedule. Efforts to achieve at-risk groups with delays are still needed despite improvements in the completeness of polio vaccines.
INTRODUÇÃO: A vacina oral contra poliomielite (VOP) pode provocar uma poliovirose derivada da vacina, o que constitui um empecilho à completa erradicação da doença. Mundialmente, está ocorrendo uma substituição gradual da VOP pela vacina injetável contra poliomielite (VIP). O Brasil adotou um esquema misto VIP-VOP desde 2012, mas nenhum estudo foi realizado para avaliar e comparar a completude e atraso aos esquemas antes e após a substituição da vacinação oral pela injetável. OBJETIVOS: Comparar a completude e o atraso vacinal de crianças menores de doze meses de idade antes e após a introdução da vacina VIP na vacinação de rotina. METODOLOGIA: Estudo tipo antes-e-depois da introdução da vacina injetável contra poliomielite, com duas coortes de nascidos vivos no município de Goiânia, Goiás. Uma coorte de nascidos vivos em 2010 recebeu o esquema vacinal exclusivamente com VOP e, outra coorte de nascidos vivos em 2014 recebeu o esquema vacinal misto VIP-VOP. Foram utilizadas duas fontes de dados secundários nominais: o do Sistema de Controle do Atendimento Ambulatorial (SICAA) que contém dados de vacinas e o Sistema de Informação de Nascidos Vivos (SINASC) que contém dados sobre a criança e a mãe. Completude do esquema vacinal foi definido como o recebimento de três doses válidas da série primária até os 12 meses de idade. Atraso vacinal foi definido como a dose de vacina administrada >28 dias após a idade recomendada. As bases de dados SICAA e SINASC foram vinculadas por meio de linkage determinístico para identificação dos registros de mesma criança. O tempo de seguimento de cada criança foi de 12 meses. RESULTADOS: Foram incluídas 23.335 crianças, sendo 9.563 da coorte de nascidos em 2010 e 13.772 da coorte de nascidos em 2014. A proporção de crianças que recebeu o esquema misto VIP-VOP apresentou 78,0% de completude vacinal, enquanto que a proporção de crianças que recebeu o esquema exclusivamente VOP apresentou 72,4% de completude vacinal (p=0.000). Ainda se observou maior proporção de atraso vacinal da 1º dose: 6,9% e 5,8%, 2° dose: 25,4% e 18,2% e, 3° dose: 31,1% e 19,3% para os esquemas vacinais VIP-VOP e exclusivamente VOP, respectivamente. As crianças que receberam o esquema misto VIP-VOP apresentaram maior mediana da idade em todas as doses, mais dias de atraso e maiores intervalos entre as doses, quando comparado com as crianças que receberam o esquema exclusivamente VOP. CONCLUSÃO: Crianças que receberam o esquema misto VIP-VOP apresentaram maior atraso vacinal, mas maior proporção de completude vacinal quando comparadas com as crianças que receberam o esquema exclusivamente VOP. Apesar de melhorias alcançadas na completude das vacinas contra a poliomielite, ainda são necessários esforços para atingir grupos de risco com atrasos.
APA, Harvard, Vancouver, ISO, and other styles
4

Mahamat, Nadjib Abderahim Saleh. "Evaluation des connaissances et des comportements des parents sur la vaccination contre la poliomyélite : enquête dans les ménages en zones urbaines et périurbaines de la ville d'Abéché à l'Est du Tchad." Thesis, Tours, 2018. http://www.theses.fr/2018TOUR3305/document.

Full text
Abstract:
L’objectif de cette thèse était d’identifier les freins et les leviers aux stratégies d’éradication de la poliomyélite dans les pays en développement puis d’analyser au travers d’un questionnaire les connaissances, attitudes et pratiques vis-à-vis de la vaccination contre la poliomyélite des parents des enfants âgés de 0 à 5 ans au Tchad. Une revue de la littérature a été effectuée en interrogeant la base de données PubMed avec des mots clés et une limitation des articles publiés entre 2010-2015 en anglais et en français pour identifier les freins et les leviers à la vaccination poliomyélite et ensuite une enquête a été mené apures des parents dans ménages de la ville d’Abéché. Les freins le plus cités étaient le refus de la vaccination, l’insécurité et les conflits armés rendant l’accès difficile aux enfants et favorisant la circulation du poliovirus. Beaucoup de pays ont pris de mesures pour améliorer la couverture vaccinale. L’enquête auprès de 210 parents a révélé qu’aucune famille ne possédait de carnet de vaccination de leurs enfants. Cependant, 97% ont déclaré avoir des enfants ayant participé aux campagnes de vaccination de masse. Près de 97 % connaissaient la poliomyélite et 98 % avaient entendu parler des campagnes de vaccination. Ce travail a permis d’identifier plusieurs freins et leviers à l’éradication de la poliomyélite. Au Tchad, les connaissances sur la maladie et le vaccin sont bonnes malgré l’existence de rumeurs concernant notamment les effets secondaires des vaccins. Néanmoins, l’absence de carnet de vaccination a limité l’analyse des résultats de l’enquête, uniquement déclarative avec un taux de vaccination très élevé déclaré
The aim of this thesis was to identify the brakes and levers for poliomyelitis eradication strategies in developing countries and then to analyze through a questionnaire the knowledge, attitudes and practices vis-à-vis poliomyelitis vaccination for parents of children aged 0-5 in Chad. A review of the literature was conducted by cross-referencing the PubMed database with keywords and a limitation of articles published between 2010-2015 in English and French to identify the barriers and levers to polio vaccination and then a survey to was conducted to relatives in the town of Abeche. The most cited barriers were the refusal of vaccination, insecurity and armed conflict, making access difficult for children and promoting the circulation of poliovirus. Many countries have taken steps to improve immunization coverage. The survey of 210 parents revealed that no family had a vaccination record of their children. However, 97% reported having children who participated in mass vaccination campaigns. Nearly 97% knew about polio and 98% had heard about vaccination campaigns. This work has identified several brakes and levers for the eradication of poliomyelitis. In Chad, knowledge of the disease and the vaccine is good despite rumors about the side effects of vaccines. Nevertheless, the lack of vaccination cards limited the analysis of the results of the survey, only declarative with a very high vaccination rate reported
APA, Harvard, Vancouver, ISO, and other styles
5

WEISS, HUBERT. "Vers l'eradication de la poliomyelite en l'an 2000 ?" Université Louis Pasteur (Strasbourg) (1971-2008), 1993. http://www.theses.fr/1993STR1M185.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

PERROTEAU, FRANCOISE. "A propos de trois cas de poliomyelite anterieure aigue en haute-vienne." Limoges, 1988. http://www.theses.fr/1988LIMO0214.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Fraipont, Florence de. "Caractérisation et utilisation des déterminants phénotypiques et moléculaires de la neurovirulence et de l'atténuation des souches de poliovirus." Strasbourg 1, 1992. http://www.theses.fr/1992STR15085.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

GEORGESCU, MARIA-MAGDALENA. "Determinants moleculaires viraux impliques dans l'etiologie et la pathogenese de la poliomyelite paralytique associee a la vaccination." Paris 6, 1996. http://www.theses.fr/1996PA066160.

Full text
Abstract:
Le but de ce travail a ete d'etablir l'etiologie de la poliomyelite paralytique associee a la vaccination (vapp) qui represente le principal desavantage de l'administration du vaccin avec des souches de poliovirus attenuees et d'analyser les mecanismes viraux responsables de son apparition. L'etiologie de la vapp a ete etudiee en comparant des souches isolees du systeme nerveux central (snc) et des selles dans 8 cas de vapp. Dans tous les cas, des poliovirus d'origine vaccinale ont ete isoles du snc. Ces souches presentaient des genotypes tres variees et, de facon surprenante, dans la moitie des cas, des degres bas de neurovirulence chez la souris transgenique. Dans 3 cas, des melanges de genotypes ont ete identifies dans les selles. Le mecanisme de selection des virus dans le snc a ete etudie par inoculation chez la souris transgenique de melanges de virus presentant differents degres de neurovirulence. La multiplication des virus dans le snc, ayant un aspect clonal dependent de la dose neuropathogene du chaque virus du melange, pourrait expliquer la presence dans le snc de virus faiblement neurovirulents a partir d'une population virale mixte extraneurale. La reversion du phenotype attenue par mutations ponctuelles dans le genome des souches vaccinales est consideree responsable de l'apparition de la vapp. La recombinaison genetique entre un virus vaccinal et un virus sauvage est presentee ici comme mecanisme alternatif de reversion des souches vaccinales vers la neurovirulence. Des trois serotypes, les souches vaccinales de type 2 ou 3 sont les plus souvent incriminees dans l'apparition des cas de vapp par l'un des mecanismes mentionnes, tandis que la souche vaccinale de type 1 demontre une innocuite presque parfaite. La caracterisation genomique et phenotypique des virus de type 1 isoles de cas de vapp a permis d'identifier de nouveaux determinants moleculaires d'attenuation et de thermosensibilite de cette souche vaccinale
APA, Harvard, Vancouver, ISO, and other styles
9

Amiell, Serge. "Tétanos, poliomyélite et diphtérie : étude du statut vaccinal de l'adulte et de la réponse immunitaire en fonction de l'âge à 3 types de vaccins." Bordeaux 2, 1990. http://www.theses.fr/1990BOR25099.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Poliomyelitis – Vaccination"

1

Smith, Jane S. Patenting the sun: Polio and the Salk vaccine. New York: W. Morrow, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Polio eradication and its discontents: An historian's journey through an international public health (un)civil war. New Delhi: Orient Blackswan, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

A tale of two drops. New Delhi: Ocean Books, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

World Health Organization. Regional Office for Africa. Progress report on the Polio Eradication Initiative in the African region, 1996/97. Belvedere, Harare, Zimbabwe: The Office, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

West Bengal Board of Madrasah Education. Polio-Cell. Polio documentation. Kolkata: West Bengal Board of Madrasah Education, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

The Cutter incident: How America's first polio vaccine led to today's growing vaccine crisis. New Haven, CT: Yale University Press, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Offit, Paul A. The Cutter incident: How America's first polio vaccine led to the growing vaccine crisis. New Haven, CT: Yale University Press, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Polio. New York: Cavendish Square, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gouverneur polio: Le Rotary sur les rives du Congo. Paris: L'Harmattan, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Veliquette, Norman. Fulfilling our promise: Rotarians volunteer in Gujarat, India. Traverse City, Mich: The War on Polio Fund, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Poliomyelitis – Vaccination"

1

Christenson, B. "Mass vaccination programme aimed at eradication of measles in Sweden." In Measles and Poliomyelitis, 37–45. Vienna: Springer Vienna, 1993. http://dx.doi.org/10.1007/978-3-7091-9278-8_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Oldstone, Michael B. A. "Poliomyelitis." In Viruses, Plagues, and History, 151–86. Oxford University Press, 2020. http://dx.doi.org/10.1093/oso/9780190056780.003.0007.

Full text
Abstract:
This chapter addresses how polio was first discovered and then controlled, the problems with its elimination, and the argument for continued vaccination to ensure control. Polio was not defined as a specific disease entity until the late seventeenth century. Meanwhile, paralytic poliomyelitis epidemics first became known in the nineteenth century. Whether or not sporadic outbreaks of paralytic poliomyelitis occurred earlier is less certain and a matter of disagreement. The chapter then looks at the three main personalities who were fundamental in developing the vaccine for poliomyelitis: Jonas Salk, Albert Sabin, and Hilary Koprowski. Jonas Salk and his colleagues chemically inactivated the poliomyelitis virus with formaldehyde and provided a vaccine that produced immunity and dramatically lowered the incidence of poliomyelitis. However, this immunity waned over time. Additionally, administration by needle made vaccinations of large populations difficult. For these and other reasons, Koprowski, Sabin, and others independently worked on the development of a vaccine with live attenuated viruses. Without such combined efforts, the vaccine would never have materialized.
APA, Harvard, Vancouver, ISO, and other styles
3

Tizard, Ian R., and Jeffrey M. B. Musser. "Poliomyelitis—1841: The triumph of vaccination." In Great American Diseases, 215–34. Elsevier, 2022. http://dx.doi.org/10.1016/b978-0-323-98925-1.00001-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

William Tong, C. Y. "Vaccine-Preventable Diseases." In Tutorial Topics in Infection for the Combined Infection Training Programme. Oxford University Press, 2019. http://dx.doi.org/10.1093/oso/9780198801740.003.0024.

Full text
Abstract:
These are diseases in which an effective preventive vaccine exists. A death that could have been prevented by vaccination is a vaccine- preventable death. The World Health Organization (WHO) has identified twenty-five diseases as vaccine preventable. This list may expand as new vaccines are being developed. The Expanded Programme on Immunization, or EPI, is vaccination programme introduced in 1974 by the WHO to all nations. The EPI initially targeted diphtheria, whooping cough, tetanus, measles, poliomyelitis, and tuberculosis. The aim was to provide universal immunization for all children by 1990 and to achieve health for all by 2000. In 2010, about 85% of children under one year of age in the world had received at least three doses of DTP vaccine (diphtheria, tetanus, and polio). Additional vaccines have now been added to the original six targets. Most countries have now added Hepatitis B (not in UK) and Haemophilus influenzae type b (Hib) to their routine infant immunization schedules, and an increasing number are in the process of adding pneumococcal conjugate vaccine and rotavirus vaccines to their schedules. Immunization is a proven tool for controlling and even eradicating infectious diseases. The immunization campaign against smallpox between 1967 and 1977 resulted in the eradication of smallpox. Apart from smallpox, the only other viral infection that was declared eradicated through vaccination campaign was rinderpest in cattle (2011), a close relative of measles virus in humans. Another major infection target for global eradication is against poliomyelitis—the global polio eradication initiative (GPEI). When the programme began in 1988, polio threatened 60% of the world’s population. Eradication of poliomyelitis is now within reach: infections have fallen by 99%; wild type polio type 2 was last detected in 1999 and declared eradicated in 2015; wild-type poliovirus type 3 has not been detected in the world since 2012. Poliovirus type 1 is the only wild- type virus in circulation and endemic transmission is only reported in Afghanistan and Pakistan. Currently, the old trivalent oral poliovirus vaccine is replaced by the more potent bivalent poliovirus type 1 and 3 vaccine. Many western countries have switched from oral vaccine to the injected inactivated vaccine to avoid the problem of vaccine- induced paralysis, which could be associated with the oral live attenuated vaccine.
APA, Harvard, Vancouver, ISO, and other styles
5

Millward, Gareth. "Poliomyelitis." In Vaccinating Britain. Manchester University Press, 2019. http://dx.doi.org/10.7765/9781526126764.00010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Smallman-Raynor, Matthew, Andrew Cliff, Keith Ord, and Peter Haggett. "Infectious Disease Control." In A Geography of Infection, 135–54. Oxford University Press, 2022. http://dx.doi.org/10.1093/oso/9780192848390.003.0006.

Full text
Abstract:
‘Infectious Disease Control’ examines the historical development of approaches to the geographical control, elimination, and eradication of infectious diseases. It begins at a local spatial scale, seven centuries ago, among the plague-ridden lazarettos of Venice. It ends at the global scale with twenty-first-century developments in the Internet-based monitoring and surveillance of infectious diseases. Basic spatial strategies for the control of infectious diseases (defensive isolation and offensive containment) are outlined, their historical development and application in the form of such measures as cordons sanitaires, isolation, and quarantine are reviewed, and their present-day forms highlighted. Vaccines and vaccination are reviewed as a second approach to disease control, alongside initiatives for the global eradication of infectious diseases such as smallpox and poliomyelitis. Disease surveillance continues to form a cornerstone of spatially focused control activities and, so, the chapter ends with a review of the evolution of disease intelligence systems down the centuries.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Poliomyelitis – Vaccination"

1

Hakeem, Luqman, and Riaz Hussain. Key Considerations: Localisation of Polio Vaccination Efforts in the Newly Merged Districts (Tribal Areas) of Pakistan. SSHAP, September 2022. http://dx.doi.org/10.19088/sshap.2022.035.

Full text
Abstract:
Poliomyelitis (polio) remains a vital global public health challenge, particularly in countries where eradication efforts are ongoing. For almost three decades, polio programme and frontline workers in Pakistan have suffered human and financial losses due to complex political and bureaucratic management, local resistance to programme efforts, and the context of cross-border insurgency and insecurity.1 Many stakeholders in Pakistan continue to have low confidence in frontline workers and polio vaccination campaigns. In this environment, it is essential that vaccination programmes localise – by taking careful account of the local context, improving local ownership of the programmes, understanding and mitigating the issues at a grassroots level, and tailoring efforts to achieve polio eradication goals. This brief draws on evidence from academic and grey literature, data on polio vaccine uptake, consultations with partners working on polio eradication in Pakistan, and the authors’ own programme implementation experience in the country. The brief reviews the social, cultural, and contextual considerations relevant to increasing polio vaccine uptake amongst vulnerable groups in Pakistan’s tribal areas. It focuses on the current country context, in the aftermath of the 2018 merger of the former Federally Administered Tribal Areas (FATA) into Khyber Pakhtunkhwa province (KPK). This brief is part of a series authored by participants from the SSHAP Fellowship, and was written by Luqman Hakeem and Riaz Hussain from Cohort 2. Contributions were provided by response partners in Pakistan including health communication and delivery staff and local administrative authorities. This brief was reviewed by Muhammad Sufyan (University of Swabi) and Ilyas Sharif (Quaid-e-Azam College of Commerce, University of Peshawar). The brief was supported by Megan Schmidt-Sane and Santiago Ripoll at the Institute of Development Studies and is the responsibility of SSHAP.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Poliomyelitis – Vaccination' for particular source types:
Journal articles Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography